| Literature DB >> 35309887 |
Ya-Jing Liang1, Qing-Wen Su2, Zhi-Ren Sheng1, Qiu-Yan Weng3, Yan-Fang Niu3, Hong-Di Zhou1, Chun-Bo Liu1.
Abstract
The topic of physical activity interventions for the treatment of Alzheimer's disease (AD) has been discussed for decades, but there are still inconsistent views on the effect of its intervention in different studies. With the increase in randomized controlled trials (RCTs), it is necessary to update newly published studies and systematically evaluate the effects of physical activity interventions. Scientific citation databases (e.g., PubMed, EMBASE, etc.) and registration databases (e.g., ISRCTN, CHICTR, etc.) were checked to screen RCTs and systematic reviews of physical activity interventions in AD. Then extract and review the intervention methods and their evaluation results in the included studies. Spearman correlation method was used to test the association between the mean difference (MD) of intervention results and activity time. The Hedges'g method was used to combine continuous data to analyze the standard MD (SMD) of different intervention types or time subgroups. The overall results show that physical activity intervention can improve the cognition, neuropsychiatric symptoms and quality of life (Qol) of AD patients, but the duration of the intervention significantly affected the outcome of the assessment. Subgroup analysis results showed that an intervention duration of 2-5 months had a significant advantage: cognitive function (Minimum Mental State Examination: SMD = 0.47, 95% CI = 0.33 ∼ 0.61, P < 0.01), neuropsychiatric symptoms (Neuropsychiatric Inventory: SMD = -0.48, 95% CI = -0.85 ∼-0.11, P < 0.01), and quality of life (Qol-AD: SMD = 0.47, 95% CI = 0.23 ∼ 0.71, P < 0.01). The systematic review and analysis results of updated RCTs suggested that short-term (2-5 months) physical activity interventions were more beneficial in improving cognitive function, neuropsychiatric symptoms and Qol in patients with AD. And there was no evidence of differences in the effectiveness of different physical activity interventions.Entities:
Keywords: Alzheimer’s disease; cognition; meta-analysis; neuropsychiatric symptoms; physical activity; quality of life; systematic review
Year: 2022 PMID: 35309887 PMCID: PMC8926300 DOI: 10.3389/fnagi.2022.830824
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
FIGURE 1Flow diagram of literature retrieval and screening (PRISMA 2020 statement).
Basic information of updated RCTs.
| Author (Year) | Age (year), mean (SD)* | Sample* | Content of interventions | Exercise time and cycle | Diagnostic criteria | Measurement instrument | Registered number | Outcomes | Bias risk@ | |
| EG | CG | |||||||||
| EG:77.4 (6.6) | EG:64 | Cycling at 50–75% of | Stretching and range-of-motion, <20% of HRR | 20–50 min a session, 3 times a week, for 6 months | CDR, MMSE | ADAS-cog,composite scores | NCT019 | The 6 month change in ADAS-cog sinificnatly less than the natural increase in AD |
| |
| EG:81.2 (8.9) | EG:12 | Multimodal training: | Clinical follow-up, without any physical training | 60 min a session, | DSM-IV, CDR, MMSE | MMSE,CDR,clock drawing test (CDT),8-foot up and go test | NA | Physical exercise program did not improve cognition, mobility and executive function in AD patients. |
| |
| EG:76.9 (7.9) | EG:329 | Moderate to hard intensity cycling, hold dumb bells | Health and social care | 60–90 min a session, | DSM-IV, MMSE | MMSE,ADAS-cog,EQ-5D-Qol,NPI | ISRCTN10 | The exercise training program improved physical fitness without slowing cognitive impairment in Alzheimer’s patients. |
| |
| EG:69.8 (7.4) | EG:107 | Moderate-to-high–intensity aerobic exercise on ergometer bicycle, cross trainer, and treadmill | Usual treatment | 60 min a session, 3 times a week, for 4 months | NINDS-ADRDA | SDMT,NPI,TUG, | NCT016 | Aerobic exercise showed significant positive effects on physical performance. |
| |
| EG:78.6 (8.4) | EG:17 | Walking, stair-climbing,resistance | RTP alone | 40 min a session, twice a week, for 6 months | NA | MMSE,Qol-AD,TUG | NCT011 | There was a significant improvement in QOL of physical exercise group. There was no difference in cognitive function between the two groups. |
| |
| EG:74 (11) | EG:30 | Aerobic exercise,60–80% | Health education | 40 min a session, 3 times a week, for 3 months | NINDS-ADRDA | MMSE,NPI,Qol-AD,ASCS-ADL,BBS | NA | MMSE, ADCS-ADL scores are significantly higher in aerobic exercise group at 3 months follow-up |
| |
| EG:70.7 (7.4) | EG:27 | Aerobic exercise,50–70% | Usual treatment | 60–90 min, 3 times a week, for 4 month | DSM-IV, MMSE | MMSEQol-ADASCS-ADL | NA | Aerobic training therapy can significantly improve the cognition, ADL and quality of life. |
| |
EG, experiment group; CG, contral group; SD, standerd deviation; CDR, Clinical Dementia Rating; SDMT, Symbol Digit Modalities Test; NPI, Neuropsychiatric Inventory; MMSE, Minimum Mental State Examination; ADAS-cog, Alzheimer’s Disease Assessment Scale - Cognition; Qol-AD, Quality of Life - Alzheimer’s Disease; ADCS-ADL, Alzheimer’s Disease Cooperative Study - Activity of Daily Living; BBS, Berg Balance Scale; TUG, Time Up and Go test; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; NINDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; NA, Not available. @bias risk evaluation. Symbol means:
FIGURE 2Overview of studies included in the previous reported meta-analysis of physical activity interventions for cognitive function, neuropsychiatric symptoms and quality of life in Alzheimer’s disease. (A) Venn plot of the included studies in the four previously reported systematic reviews. (B) Spearman correlation test between the intervention time and the delta-means of ADAS_cog, MMSE, NPI, and Qol-AD. (C) Distribution of dementia and corresponding intervention types and counties of all included studies. (D) Distribution of intervention types and corresponding conclusions of all included studies (ADAS_cog, Alzheimer’s Disease Assessment Scale - Cognition; MMSE, Minimum Mental State Examination; NPI, Neuropsychiatric Inventory Questionnaire; Qol-AD, quality of life - Alzheimer’s Disease; delta-means, the difference between the results of each reevaluation and the baseline in each study).
Correlation test of means change difference (delta-means) at different time points.
| Subgroup | Cat. | ADAS-cog | MMSE | NPI | Qol-AD | TUG |
| All |
| 20 | 33 | 20 | 7 | 6 |
| T | 0,2,3,4,6 | 0,2,3,4,6,12 | 0,2,3,4,6,12 | 0,3,6 | 0,3,12 | |
|
| −0.39 | 0.48 | −0.62 | 0.87 | −0.52 | |
|
| 0.089 |
|
|
| 0.29 | |
| CNKI database |
| 14 | 16 | 8 | 3 | . |
|
| 0,2,3,6 | 0,2,3,4,6 | 0,2,3,4,6 | 0,3,6 | . | |
|
| −0.54 | 0.75 | −0.76 | 1 | . | |
|
|
|
|
| 0.33 | . | |
| Other databases |
| 6 | 17 | 12 | 4 | 6 |
|
| 0,3,4 | 0,3,4,6,12 | 0,3,4,6,12 | 0,3,6 | 0,3,12 | |
|
| −0.4 | 0.32 | −0.5 | 0.95 | −0.52 | |
|
| 0.43 | 0.21 | 0.1 | 0.051 | 0.29 | |
| Aerobic exercise |
| 18 | 20 | 12 | 5 | 2 |
|
| 0,2,3,4,6 | 0,2,3,4,6 | 0,2,3,4,6 | 0,3,6 | 0,4 | |
|
| −0.39 | 0.58 | −0.74 | 0.95 | −1 | |
|
| 0.11 |
|
|
| 1 | |
| Other exercise |
| 2 | 13 | 8 | 2 | 4 |
|
| 0,4 | 0,3,4,6,12 | 0,3,6,12 | 0,6 | 0,3,12 | |
|
| −1 | 0.36 | −0.25 | 1 | −0.74 | |
|
| 1 | 0.23 | 0.56 | 1 | 0.26 |
MMSE, Minimum Mental State Examination; NPI, Neuropsychiatric Inventory; Qol-AD, Quality of Life - Alzheimer’s Disease; ADAS-cog, Alzheimer’s Disease Assessment Scale - Cognition; n, total number of assessment points; T, assessemnt time point (months); Rho, Spearman correlation coefficient; P, P value; TUG, timed up and go (s); CNKI, China national knowledge infrastructure. Bold value indicate a P-value less than 0.05.
FIGURE 3Pooled SMD forest plot of the results of physical activity intervention on MMSE, ADAS_cog, NPI, and Qol-AD. (SMD, standard mean difference; ADAS_cog, Alzheimer’s Disease Assessment Scale - Cognition; MMSE, Minimum Mental State Examination; NPI, Neuropsychiatric Inventory Questionnaire; Qol-AD, Quality of Life - Alzheimer’s Disease).
Updated subgroup stratified meta-analysis results.
| Groups | Subgroups | Cat. |
| SMD | [LCI;UCI] |
|
| I2 (%) | Meta-reg |
| MMSE | > 5mon | Fixed | 24 | 0.249 | [0.128;0.369] | 4.05 |
| 73.60 | ∼Time: |
| Random | 0.392 | [0.144;0.640] | 3.1 |
| |||||
| Aerobic | Fixed | 14 | 0.205 | [0.068;0.342] | 2.95 |
| 75.70 | ||
| Random | 0.331 | [0.041;0.621] | 2.24 |
| |||||
| Other | Fixed | 10 | 0.399 | [0.144;0.654] | 3.07 |
| 71.80 | ||
| Random | 0.505 | [0.014;0.997] | 2.02 |
| |||||
| <5mon | Fixed | 17 | 0.471 | [0.334;0.608] | 6.73 |
| 42.20 | ||
| Random | 0.553 | [0.361;0.745] | 5.65 |
| |||||
| Aerobic | Fixed | 12 | 0.427 | [0.279;0.573] | 5.69 |
| 48.60 | ||
| Random | 0.51 | [0.292;0.723] | 4.63 |
| |||||
| Other | Fixed | 5 | 0.767 | [0.386;1.147] | 3.95 |
| 0.00 | ||
| Random | 0.767 | [0.386;1.147] | 3.95 |
| |||||
| ADAS-cog | > 5mon | Fixed | 14 | −0.094 | [−0.213;0.025] | −1.54 | 0.12 | 74.00 | ∼Time: |
| Random | −0.235 | [−0.491;0.019] | −1.81 | 0.07 | |||||
| Aerobic | Fixed | 12 | −0.147 | [−0.291; −0.003] | −2.01 |
| 76.70 | ||
| Random | −0.287 | [−0.601;0.027] | −1.79 | 0.07 | |||||
| Other | Fixed | 2 | 0.024 | [−0.190;0.240] | 0.23 | 0.82 | 4.90 | ||
| Random | 0.018 | [−0.216;0.253] | 0.15 | 0.88 | |||||
| <5mon | Fixed | 11 | −0.106 | [−0.237;0.025] | −1.58 | 0.11 | 60.40 | ||
| Random | −0.24 | [−0.473; −0.008] | −2.03 |
| |||||
| Aerobic | Fixed | 9 | −0.198 | [−0.364; −0.033] | −2.36 |
| 43.20 | ||
| Random | −0.251 | [−0.485; −0.017] | −2.1 |
| |||||
| Other | Fixed | 2 | 0.052 | [−0.163;0.269] | 0.48 | 0.63 | 87.30 | ||
| Random | −0.281 | [−1.240;0.678] | −0.57 | 0.57 | |||||
| NPI | > 5mon | Fixed | 13 | −0.067 | [−0.201;0.067] | −0.98 | 0.33 | 71.20 | ∼Time: |
| Random | −0.173 | [−0.446;0.100] | −1.24 | 0.21 | |||||
| Aerobic | Fixed | 8 | 0.039 | [−0.127;0.206] | 0.46 | 0.64 | 0.00 | ||
| Random | 0.039 | [−0.127;0.206] | 0.48 | 0.64 | |||||
| Other | Fixed | 5 | −0.265 | [−0.492; −0.038] | −2.29 |
| 88.30 | ||
| Random | −0.824 | [−1.617; −0.030] | −2.04 |
| |||||
| <5mon | Fixed | 10 | −0.303 | [−0.463; −0.143] | −3.72 |
| 76.70 | ||
| Random | −0.478 | [−0.845; −0.111] | −2.56 |
| |||||
| Aerobic | Fixed | 7 | −0.277 | [−0.456; −0.097] | −3.02 |
| 0.00 | ||
| Random | −0.277 | [−0.456; −0.097] | −3.02 |
| |||||
| Other | Fixed | 3 | −0.402 | [−0.752; −0.053] | −2.26 |
| 94.40 | ||
| Random | −1.795 | [−4.328;0.738] | −1.39 | 0.16 | |||||
| Qol-AD | > 5mon | Fixed | 8 | 0.015 | [−0.181;0.212] | 0.15 | 0.88 | 24.20 | ∼Time: |
| Random | 0.013 | [−0.214;0.239] | 0.11 | 0.91 | |||||
| Aerobic | Fixed | 6 | 0.03 | [−0.185;0.245] | 0.27 | 0.79 | 36.60 | ||
| Random | 0.027 | [−0.243;0.299] | 0.2 | 0.84 | |||||
| Other | Fixed | 2 | −0.057 | [−0.535;0.420] | −0.24 | 0.81 | 19.10 | ||
| Random | −0.057 | [−0.588;0.473] | −0.21 | 0.83 | |||||
| <5mon | Fixed | 5 | 0.471 | [0.231;0.710] | 3.85 |
| 0.00 | ||
| Random | 0.471 | [0.231;0.710] | 3.85 |
| |||||
| Aerobic | Fixed | 5 | 0.471 | [0.231; 0.710] | 3.85 |
| 0.00 | ||
| Random | 5 | 0.471 | [0.231; 0.710] | 3.85 |
| 0.00 |
MMSE, Minimum Mental State Examination; NPI, Neuropsychiatric Inventory; Qol-AD, Quality of Life - Alzheimer’s Disease; ADAS-cog, Alzheimer’s Disease Assessment Scale - Cognition; Cat., category; SMD, standard mean difference with Hedges’ g as effect measure; LCI, lower confidence interval; UCI, upper confidence interval; Z,P, statistic and p-value in Hedges’g test; I
FIGURE 4Compared the delta-means generated between baseline and intervention outcomes. (A) T-tests of the delta-means of MMSE, ADAS_cog, NPI and Qol-AD at different intervention times. (B) T-tests of the delta-means between aerobic and other exercise of MMSE, ADAS_cog, NPI, and Qol-AD. (ADAS_cog, Alzheimer’s Disease Assessment Scale - Cognition; MMSE, Minimum Mental State Examination; NPI, Neuropsychiatric Inventory Questionnaire; Qol-AD, Quality of Life - Alzheimer’s Disease; delta-means, the difference between the results of each reevaluation and the baseline in each study).